Results 271 to 280 of about 621,634 (301)
Some of the next articles are maybe not open access.
Zeitschrift für Rheumatologie, 2017
Therapy reduction in rheumatoid arthritis (RA) is still a challenge for physicians as well as for patients. Effective therapy with subsequent achievement of low disease activity or even remission is achievable for numerous patients using currently available treatment options.
D, Aletaha, A, Kerschbaumer
openaire +2 more sources
Therapy reduction in rheumatoid arthritis (RA) is still a challenge for physicians as well as for patients. Effective therapy with subsequent achievement of low disease activity or even remission is achievable for numerous patients using currently available treatment options.
D, Aletaha, A, Kerschbaumer
openaire +2 more sources
Hospital Practice, 1979
Why self-perpetuating joint destruction is intermittent in some patients and unrelenting in others remains largely unknown, but progress has been made in identifying the different types of clinical course and tailoring specific treatment regimens for each.
openaire +2 more sources
Why self-perpetuating joint destruction is intermittent in some patients and unrelenting in others remains largely unknown, but progress has been made in identifying the different types of clinical course and tailoring specific treatment regimens for each.
openaire +2 more sources
Drugs of Today, 1998
Rheumatoid arthritis (RA) is a common systemic, inflammatory, rheumatic disease of unknown etiology manifest by a chronic symmetric polyarthritis, particularly involving the small distal joints. Pathogenesis may involve inappropriate T-cell activation or lack of appropriate inhibition, although newer theories center on the importance of cytokines and ...
openaire +2 more sources
Rheumatoid arthritis (RA) is a common systemic, inflammatory, rheumatic disease of unknown etiology manifest by a chronic symmetric polyarthritis, particularly involving the small distal joints. Pathogenesis may involve inappropriate T-cell activation or lack of appropriate inhibition, although newer theories center on the importance of cytokines and ...
openaire +2 more sources
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis
New England Journal of Medicine, 2022Deepak L Bhatt, Jose L Rivas
exaly
The immunopathogenesis of seropositive rheumatoid arthritis: from triggering to targeting
Nature Reviews Immunology, 2016Vivianne Malmström, Lars Klareskog
exaly